Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study - PubMed (original) (raw)
. 2000 Oct 4;92(19):1582-92.
doi: 10.1093/jnci/92.19.1582.
Affiliations
- PMID: 11018094
- DOI: 10.1093/jnci/92.19.1582
Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study
A L Potosky et al. J Natl Cancer Inst. 2000.
Abstract
Background: Radical prostatectomy and external beam radiotherapy are the two major therapeutic options for treating clinically localized prostate cancer. Because survival is often favorable regardless of therapy, treatment decisions may depend on other therapy-specific health outcomes. In this study, we compared the effects of two treatments on urinary, bowel, and sexual functions and on general health-related quality-of-life outcomes over a 2-year period following initial treatment.
Methods: A diverse cohort of patients aged 55-74 years who were newly diagnosed with clinically localized prostate cancer and received either radical prostatectomy (n = 1156) or external beam radiotherapy (n = 435) were included in this study. A propensity score was used to balance the two treatment groups because they differed in some baseline characteristics. This score was used in multivariable cross-sectional and longitudinal regression analyses comparing the treatment groups. All statistical tests were two-sided.
Results: Almost 2 years after treatment, men receiving radical prostatectomy were more likely than men receiving radiotherapy to be incontinent (9.6% versus 3.5%; P:<.001) and to have higher rates of impotence (79.6% versus 61.5%; P:<.001), although large, statistically significant declines in sexual function were observed in both treatment groups. In contrast, men receiving radiotherapy reported greater declines in bowel function than did men receiving radical prostatectomy. All of these differences remained after adjustments for propensity score. The treatment groups were similar in terms of general health-related quality of life.
Conclusions: There are important differences in urinary, bowel, and sexual functions over 2 years after different treatments for clinically localized prostate cancer. In contrast to previous reports, these outcome differences reflect treatment delivered to a heterogeneous group of patients in diverse health care settings. These results provide comprehensive and representative information about long-term treatment complications to help guide and inform patients and clinicians about prostate cancer treatment decisions.
Comment in
- Re: Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.
Dalkin BL. Dalkin BL. J Natl Cancer Inst. 2001 Mar 7;93(5):401-2. doi: 10.1093/jnci/93.5.401. J Natl Cancer Inst. 2001. PMID: 11238710 No abstract available.
Similar articles
- Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC. Potosky AL, et al. J Natl Cancer Inst. 2004 Sep 15;96(18):1358-67. doi: 10.1093/jnci/djh259. J Natl Cancer Inst. 2004. PMID: 15367568 - Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer.
Chen RC, Basak R, Meyer AM, Kuo TM, Carpenter WR, Agans RP, Broughman JR, Reeve BB, Nielsen ME, Usinger DS, Spearman KC, Walden S, Kaleel D, Anderson M, Stürmer T, Godley PA. Chen RC, et al. JAMA. 2017 Mar 21;317(11):1141-1150. doi: 10.1001/jama.2017.1652. JAMA. 2017. PMID: 28324092 Free PMC article. - Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer.
Madalinska JB, Essink-Bot ML, de Koning HJ, Kirkels WJ, van der Maas PJ, Schröder FH. Madalinska JB, et al. J Clin Oncol. 2001 Mar 15;19(6):1619-28. doi: 10.1200/JCO.2001.19.6.1619. J Clin Oncol. 2001. PMID: 11250990 - Quality of life following radical prostatectomy.
Kirschner-Hermanns R, Jakse G. Kirschner-Hermanns R, et al. Crit Rev Oncol Hematol. 2002 Aug;43(2):141-51. doi: 10.1016/s1040-8428(02)00026-4. Crit Rev Oncol Hematol. 2002. PMID: 12191736 Review. - Incontinence and erectile dysfunction following radical prostatectomy: a review.
Alivizatos G, Skolarikos A. Alivizatos G, et al. ScientificWorldJournal. 2005 Sep 13;5:747-58. doi: 10.1100/tsw.2005.94. ScientificWorldJournal. 2005. PMID: 16170437 Free PMC article. Review.
Cited by
- The Treatment of Localized Prostate Cancer in Everyday Practice in Germany.
Herden J, Ansmann L, Ernstmann N, Schnell D, Weißbac L. Herden J, et al. Dtsch Arztebl Int. 2016 May 13;113(19):329-36. doi: 10.3238/arztebl.2016.0329. Dtsch Arztebl Int. 2016. PMID: 27232362 Free PMC article. - Millon Behavioral Medicine Diagnostic (MBMD) Predicts Health-Related Quality of Life (HrQoL) over time among men treated for localized prostate cancer.
Cruess DG, Benedict C, Lattie EG, Molton I, Kinsinger D, Kava B, Manoharan M, Soloway M, Penedo FJ. Cruess DG, et al. J Pers Assess. 2013;95(1):54-61. doi: 10.1080/00223891.2012.681819. Epub 2012 May 9. J Pers Assess. 2013. PMID: 22571442 Free PMC article. - Effects of surgeon variability on oncologic and functional outcomes in a population-based setting.
Carlsson S, Berglund A, Sjoberg D, Khatami A, Stranne J, Bergdahl S, Lodding P, Aus G, Vickers A, Hugosson J. Carlsson S, et al. BMC Urol. 2014 Mar 6;14:25. doi: 10.1186/1471-2490-14-25. BMC Urol. 2014. PMID: 24602348 Free PMC article. Clinical Trial. - The Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.
Resnick MJ, Barocas DA, Morgans AK, Phillips SE, Koyama T, Albertsen PC, Cooperberg MR, Goodman M, Greenfield S, Hamilton AS, Hoffman KE, Hoffman RM, Kaplan SH, McCollum D, Paddock LE, Stanford JL, Stroup AM, Wu XC, Penson DF. Resnick MJ, et al. Eur Urol. 2015 Jun;67(6):1019-1025. doi: 10.1016/j.eururo.2014.08.035. Epub 2014 Aug 28. Eur Urol. 2015. PMID: 25174325 Free PMC article. - The association of long-term treatment-related side effects with cancer-specific and general quality of life among prostate cancer survivors.
Davis KM, Kelly SP, Luta G, Tomko C, Miller AB, Taylor KL. Davis KM, et al. Urology. 2014 Aug;84(2):300-6. doi: 10.1016/j.urology.2014.04.036. Epub 2014 Jun 26. Urology. 2014. PMID: 24975711 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical